AI科研突破!MirrorPeptidizer斩获GOAI全球开源AI大赛全场大奖

A Chinese research team takes home the Grand Prize of 1 million RMB at the 2026 Global Open‑source AI Challenge (GOAI). Their project MirrorPeptidizer, a de‑novo D‑peptide (mirror‑image peptide) design algorithm, beat over 14,000 developers across 91 countries and regions.
中国科研团队拿下2026世界人工智能开源大赛GOAI百万人民币全场大奖。项目MirrorPeptidizer,一套镜像多肽(D‑肽)从头设计算法,击败来自91个国家与地区的14000余名开发者。
This AI addresses key bottlenecks in drug discovery. It designs highly protease‑resistant mirror‑image peptides within a virtual mirror space. The same model also drives in‑situ R&D of gut‑derived probiotics for Vsmile, supporting computer‑aided screening of drug molecules and functional gut bacteria.
该AI攻克药物研发关键瓶颈,可在虚拟镜像空间设计抗蛋白酶降解的镜像多肽。这套获奖模型同时服务微司麦原位人体益生菌研发,用计算机模拟完成药物分子、肠道功能菌株的前期筛选。
The model is already adopted in innovative‑drug research at Huadong Medicine. Prize money will be reinvested into further scientific research.
模型已应用于华东医药创新药研发,奖金将继续投入科学研究。

